
Protagonist Therapeutics Investor Relations Material
Latest events

Status Update
Protagonist Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Protagonist Therapeutics Inc
Access all reports
Protagonist Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative peptide-based therapeutic drugs aimed at addressing unmet medical needs. The company's focus encompasses a broad range of diseases, with a particular emphasis on rare and prevalent conditions where existing treatments are limited or inadequate. Protagonist Therapeutics' technology platform has produced a pipeline of promising drug candidates, including peptide-based drugs for hematology and blood disorders, as well as inflammatory and immunomodulatory diseases.
Key slides for Protagonist Therapeutics Inc


Investor Update
Protagonist Therapeutics Inc


Status Update
Protagonist Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
PTGX
Country
🇺🇸 United States